Creo Medical Group PLC
LSE:CREO
Creo Medical Group PLC
LSE:CREO
Price:
36.5 GBX
Market Closed
Updated:
May 22, 2024
Creo Medical Group PLC
Selling, General & Administrative
|
Creo Medical Group PLC
Selling, General & Administrative Peer Comparison
Comparables:
SN
LIVN
LMDX
EKF
AGL
Competitive Selling, General & Administrative Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Selling, General & Administrative | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Creo Medical Group PLC
LSE:CREO
|
Selling, General & Administrative
-£43.9m
|
CAGR 3-Years
-32%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Smith & Nephew PLC
LSE:SN
|
Selling, General & Administrative
-$2.6B
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-4%
|
CAGR 10-Years
N/A
|
|
|
LivaNova PLC
NASDAQ:LIVN
|
Selling, General & Administrative
-$523.9m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-1%
|
CAGR 10-Years
-16%
|
|
|
LumiraDx Ltd
NASDAQ:LMDX
|
Selling, General & Administrative
-$127.3m
|
CAGR 3-Years
-58%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
EKF Diagnostics Holdings PLC
LSE:EKF
|
Selling, General & Administrative
-£16m
|
CAGR 3-Years
4%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-1%
|
|
|
Angle PLC
LSE:AGL
|
Selling, General & Administrative
N/A
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Creo Medical Group PLC's Selling, General & Administrative?
Selling, General & Administrative
-43.9m
GBP
-43.9m
GBP
Based on the financial report for Dec 31, 2022, Creo Medical Group PLC's Selling, General & Administrative amounts to -43.9m GBP.
What is Creo Medical Group PLC's Selling, General & Administrative growth rate?
Selling, General & Administrative CAGR 3Y
-32%
-32%
Over the last year, the Selling, General & Administrative growth was -6%. The average annual Selling, General & Administrative growth rates for Creo Medical Group PLC have been -32% over the past three years .
You don't have any saved screeners yet
